Td Asset Management Inc Kodiak Sciences Inc. Transaction History

Td Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$4.3 - $9.48 $151,252 - $333,459	35,175 New	35,175 $242,000
Q4 2022 Feb 06, 2023	SELL	$6.52 - $8.05 $175,388 - $216,545	-26,900 Reduced 48.05%	29,086 $208,000
Q3 2022 Nov 07, 2022	BUY	$7.57 - $12.5 $757 - $1,250	100 Added 0.18%	55,986 $425,000
Q1 2022 May 10, 2022	SELL	$7.09 - $89.45 $1.29 Million - $16.3 Million	-182,485 Reduced 76.56%	55,886 $431,000
Q4 2021 Feb 10, 2022	BUY	$80.85 - $128.49 $5.36 Million - $8.51 Million	66,246 Added 38.49%	238,371 $20.2 Million
Q3 2021 Nov 09, 2021	BUY	$81.97 - $106.94 $1.45 Million - $1.89 Million	17,703 Added 11.46%	172,125 $16.5 Million
Q2 2021 Aug 11, 2021	BUY	$77.2 - $126.54 $1.27 Million - $2.08 Million	16,453 Added 11.93%	154,422 $12.9 Million
Q1 2021 May 14, 2021	BUY	$110.45 - $164.47 $2.96 Million - $4.41 Million	26,798 Added 24.11%	137,969 $15.6 Million
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $1.01 Million - $2.56 Million	16,610 Added 17.57%	111,171 $16.3 Million
Q3 2020 Nov 10, 2020	BUY	$45.05 - $59.27 $116,274 - $152,975	2,581 Added 2.81%	94,561 $5.6 Million
Q2 2020 Aug 13, 2020	BUY	$42.74 - $66.25 $149,077 - $231,080	3,488 Added 3.94%	91,980 $4.98 Million
Q1 2020 May 15, 2020	BUY	$38.18 - $73.95 $250,193 - $484,594	6,553 Added 8.0%	88,492 $4.22 Million
Q4 2019 Feb 11, 2020	BUY	$13.9 - $76.65 $971,582 - $5.36 Million	69,898 Added 580.5%	81,939 $5.9 Million
Q3 2019 Nov 07, 2019	BUY	$10.24 - $17.57 $123,299 - $211,560	12,041 New	12,041 $173,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.